DailyDoctor Archive Specialties Get app
Back to the 26 September 2026 edition

Practice changer · 06 of 06

Do not give routine prophylactic dextrose gel to at-risk newborns

Do not give prophylactic dextrose gel routinely to at-risk newborns; it did not improve school-age neurodevelopment.

Design
School-age follow-up of a multicentre, double-blind, placebo-controlled RCT
Population
1,067 children born at ≥35 weeks with risk factors for neonatal hypoglycaemia
Primary outcome
Neurocognitive impairment at 6–7 years
Effect
59% vs 57%; adjusted risk difference 3% (95% CI −3% to 9%)

The hPOD trial in nine New Zealand hospitals randomised at-risk late preterm and term newborns — preterm, maternal diabetes, small or large for gestational age — to a single 0.2 g/kg dose of buccal dextrose gel or placebo at one hour of age. This school-age follow-up assessed 1,067 children (82–83% of those eligible) at 6–7 years.

Neurocognitive impairment was similar: 59% after gel and 57% after placebo (adjusted risk difference 3%, 95% CI −3% to 9%). Among exploratory outcomes, children who had received gel were more likely to have emotional-behavioural difficulty (24% vs 18%) and low psychosocial function (17% vs 12%).

The exploratory findings need confirmation, but there is no longer-term benefit to set against them. The authors conclude the evidence does not support routine prophylactic gel. Dextrose gel as a treatment for established hypoglycaemia is a different question and is not addressed here.

  • Stop routine prophylactic dextrose gel for at-risk newborns if your unit uses it.
  • Continue to use dextrose gel as treatment for confirmed hypoglycaemia where your protocol supports it.
  • Prioritise early feeding and timed glucose monitoring in at-risk babies.
  • Share this evidence with obstetric and midwifery teams who may start gel at delivery.

Why it matters

It removes a preventive intervention that many units adopted, with a hint that it may do harm.

Don't overread it

The wellbeing harms were exploratory outcomes; the trial does not address gel used as treatment.

The statistics, in plain English

The adjusted risk difference of 3% with a confidence interval from −3% to 9% means no detectable benefit and a possible small harm. The emotional-behavioural results were exploratory among 11 outcomes, so one or two could be chance findings, but they point the same way.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

paedinfectpaedrespneonataladolescentgrowth

Tomorrow morning, before your first patient

One edition a day for paediatrics, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app